St. Boyce et al., COMPARATIVE-ASSESSMENT OF CULTURED SKIN SUBSTITUTES AND NATIVE SKIN AUTOGRAFT FOR TREATMENT OF FULL-THICKNESS BURNS, Annals of surgery, 222(6), 1995, pp. 743-752
Objective Comparison of cultured skin substitutes (CSSs) and split-thi
ckness autograft (STAG) was performed to assess whether the requiremen
t for autologous skin grafts may be reduced in the treatment of massiv
e burns. Summary Background Data Cultured skin substitutes consisting
of collagen-glycosaminoglycan substrates populated with autologous fib
roblasts and keratinocytes have been demonstrated to close full-thickn
ess skin wounds in athymic mice and to express normal skin antigens af
ter closure of excised wounds in burn patients. Methods Data were coll
ected from 17 patients between days 2 and 14 to determine incidence of
exudate, incidence of regrafting, coloration, keratinization, and per
centage of site covered by graft (n = 17). Outcome was evaluated on an
ordinal scale (0 = worst; 10 = best) beginning at day 14, with primar
y analyses at 28 days (n =10)and 1 year(n = 4) for erythema, pigmentat
ion, epithelial blistering, surface roughness, skin suppleness, and ra
ised scar. Results Sites treated with CSSs had increased incidence of
exudate (p = 0.06) and decreased percentage of engraftment (p < 0.05)
compared with STAG. Outcome parameters during the first year showed no
differences in erythema, blistering, or suppleness. Pigmentation was
greater, scar was less raised, but regrafting was more frequent in CSS
sites than STAG. No differences in qualitative outcomes were found af
ter 1 year, and antibodies to bovine collagen were not detected in pat
ient sera. Conclusions These results suggest that outcome of engrafted
CSSs is not different from STAG and that increased incidence of regra
fting is related to decreased percentage of initial engraftment. Incre
ased rates of engraftment of CSSs may lead to improved outcome for clo
sure of burn wounds, allow greater availability of materials for graft
ing, and reduce requirements for donor skin autograft.